Evidence map›Paper›PMID 34775516›Full record

ArticleJournal of cancer research and clinical oncology2022

Vasculogenic mimicry correlates to presenting symptoms and mortality in uveal melanoma.

Shiva Sabazade, Viktor Gill, Christina Herrspiegel, Gustav Stålhammar

Open access · hybridAbstract read
In one paragraph

Article in Journal of cancer research and clinical oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Shiva SabazadeSt. Erik Eye Hospital, Stockholm, Sweden.
Viktor GillDepartment of Clinical Neuroscience, Karolinska Institutet, Eugeniavägen 12, 17164, Stockholm, Sweden.
Christina HerrspiegelSt. Erik Eye Hospital, Stockholm, Sweden.
Gustav StålhammarSt. Erik Eye Hospital, Stockholm, Sweden. gustav.stalhammar@ki.se.ORCID http://orcid.org/0000-0001-9401-8911
Karolinska Institutet · SE

Funding

Cancerfonden 20 0798 FkCarmen and Bertil Regnér Foundation 2020-00062Karolinska Institutet 2020-013333Karolinska Institutet 2020-02517Ögonfonden 2020-04-27Region Stockholm 20200356Royal Swedish Academy of Sciences ME2019-0036Stiftelsen Kronprinsessan Margaretas Arbetsnämnd för Synskadade 157Svenska Läkaresällskapet Cronqvists stiftelseSvenska Läkaresällskapet SLS 934014
6 · The paper itself

Abstract

purposeFluid-conducting extracellular matrix patterns known as vasculogenic mimicry (VM) have been associated with poor prognosis in uveal melanoma and other cancers. We investigate the correlations between VM, presenting symptoms, mortality, and the area density of periodic acid-Schiff positive histological patterns (PAS density).

methodsSixty-nine patients that underwent enucleation for uveal melanoma between 2000 and 2007 were included. Clinicopathological parameters presenting symptoms and outcomes were collected. Histological tumor sections were evaluated for VM and PAS density was quantified with digital image analysis.

resultsThirty-four patients (49%) presented with blurred vision. 18 (26%) with a shadow in the visual field, 7 (10%) with photopsia and/or floaters, and 2 (3%) with metamorphopsia. Nine patients (13%) had no symptoms at all. Median follow-up was 16.7 years (SD 2.6). A shadow in the visual field, but no other symptom, was positively correlated with the presence of VM (φ 0.70, p < 0.001) and greater PAS density (p < 0.001). In multivariate regression, retinal detachment (RD), presence of VM, and PAS density ≥ median were independent predictors of a shadow, but not tumor distance to the macula, tumor apical thickness, tumor diameter, or ciliary body engagement. The presence of VM was associated with significantly shorter cumulative disease-specific survival (Wilcoxon p = 0.04), but not PAS density ≥ median, presenting symptoms or RD (p > 0.28).

conclusionTumors from uveal melanoma patients that report a visual field shadow are likely to display VM and greater PAS density, likely explaining the previously reported association between this symptom and poor prognosis.

Indexed as

FemaleFollow-Up StudiesHumansMaleMelanomaMiddle AgedNeovascularization, PathologicPrognosisRetrospective StudiesSurvival RateUveal MelanomaUveal NeoplasmsOncologyPAS densityPathologyPrognosisUveal melanomaVasculogenic mimicry

Identifiers

PMID34775516
PMCPMC8881423
OpenAlexW3205545907

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.